official impact factor

5.79

Advanced search

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A

Julian Puppe, Rinske Drost, Xiaoling Liu, Simon A Joosse, Bastiaan Evers, Paulien Cornelissen-Steijger, Petra Nederlof, Qiang Yu, Jos Jonkers^*^†, Maarten van Lohuizen^*^† and Alexandra M Pietersen^*^†

* Corresponding authors: Jos Jonkers j.jonkers@nki.nl - Maarten van Lohuizen m.v.lohuizen@nki.nl - Alexandra M Pietersen gmsamp@nus.edu.sg
† Equal contributors

Breast Cancer Research 2009, 11:R63 doi:10.1186/bcr2354

Accesses

Last 30 days: 102 accesses
Last year: 1297 accesses
All time: 5577 accesses

Cited by

BioMed Central: 1 citation

Development of 'synthetic lethal' strategies to target BRCA1-deficient breast cancer

Max S Wicha Breast Cancer Research 2009, 11:108 (23 September 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations